Navigation Links
GeoPharma Announces Record Revenues in Third Quarter Results
Date:2/14/2008

5,853,929 3,742,952 13,400,893 11,011,141

Operating income (loss)

before other income and

expense, minority

interest, income taxes

and discontinued

operations $(2,278,474) $773,477 $(7,083,303) $1,676,915

Other income (expense),

net:

Other income (expense),

net 10,793 (410) 11,318 163,889

Interest income (expense),

net (240,311) (33,790) (313,277) (62,406)

Total other income

(expense), net $(229,518) $(34,200) $(301,959) $101,483

Income (loss) before

minority interest,

income taxes and

discontinued operations $(2,507,992) $739,277 $(7,385,262) $1,778,398

Minority interest benefit

(expense) 202,495 319,998 644,951 984,328

Income tax benefit

(expense) 729,951 (300,000) 2,415,353 (888,000)

Net income (loss) from

continuing operations $(1,575,546) $759,275 $(4,324,958) $1,874,726

Discontinued operations:

Revenues: PBM $-- $-- $2,925,139 $--

Cost of goods sold: PBM -- -- 2,904,274 --

Gross profit: PBM $-- $-- 20,865 $--

Selling, general and

administrative

expenses: PBM -- -- 20,785 --

PBM segment exit income

(expense) -- -- 8,300 --

Discontinued operations

net income (net of

income tax) $-- $-- $8,380 $--

Net income (loss) $(1,575,546) $759,275 $(4,316,578) $1,874,726

Preferred stock dividends 100,001 75,000 308,336 225,000

Net income (loss)

available to common

sha
'/>"/>

SOURCE GeoPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. GeoPharma Announces Third Quarter Conference Call
2. GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen
3. Angiotech announces results for the fourth quarter ended December 31, 2007
4. Cell Therapeutics, Inc. (CTI) Announces Cancellation of Approximately $9.1 Million of Existing Notes due 2008
5. Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
6. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
7. NightHawk Radiology Holdings, Inc. Announces Senior Executive Departures
8. VLST Corporation Announces Board and Executive Management Appointments
9. Advance Nanotech Announces Shareholder Proxy Vote Results
10. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
11. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 Cynvenio, a cancer ... through the genomic analysis of tumor cells in the ... a web-based cancer decision support application powered by CollabRx, ... Cynvenio’s ClearID™ genomic test, Therapy Finder will provide breast ...
(Date:1/15/2014)... England , January 15, 2014 A ... win races on the Formula 1 track could help to ... McLaren Applied Technologies (MAT), Stowhealth (a GP surgery based in ... by healthcare provider Simplyhealth. Telemetry technology, which is ...
(Date:1/15/2014)... DTS Language Services, Inc . is ... for Life Science organizations who need document translations. Clients ... of their documents in advance with a selection of nearly ... translations, often a critical factor in clinical and scientific fields, ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4DTS Improves Efficiency for Life Science Document Translations 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... Microscopic robots crafted to maneuver separately without any obvious ... of continuing research led by a Duke University computer ... assembly and control at this fine a resolution with ... Duke professor of computer science and biochemistry. , Each ...
... Pharmaceuticals,Inc. (Nasdaq: AMLN ) today announced that ... diabetes drugs, BYETTA(R) (exenatide) injection and,SYMLIN(R) (pramlintide acetate) ... at the American Diabetes Association,s 68th Annual,Scientific Sessions ... June 6 to,10. The company will also host ...
... June 2 , CALL DATE: Tuesday, June 3, 2008, ... Time, HOST: Dr. Candace ... conduct a telephone conference call and,simultaneous webcast on Tuesday, June 3 ... Research Corporation that,was announced on May 30 and to provide an ...
Cached Biology Technology:Microrobots dance on something smaller than a pin's head 2Microrobots dance on something smaller than a pin's head 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 2Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 3Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 4Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 5Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 6Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008 7Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress 2
(Date:4/23/2014)... HUNTSVILLE, TX (4/23/14) -- Researchers have found evidence ... risk factors that increase aggressive behavior in children, ... that not all children exposed to prenatal smoking ... others will not," said Brian Boutwell, Assistant Professor ... Justice and senior author on the study. ...
(Date:4/23/2014)... as an antimicrobial ingredient in soaps, toothpastes and other ... new evidence that appears to support these worries. Their ... in Toxicology , found that triclosan, as well as ... human breast cancer cells in lab dishes and breast ... note that hormonal imbalances seem to play a role ...
(Date:4/23/2014)... study to date of the family of bacteria ... vaccine strategies and reveals surprising findings about the ... alter public health strategies to control this respiratory ... , Genomic analysis of 343 strains of the ... world collected over the last 100 years illustrates ...
Breaking Biology News(10 mins):Genetics risk, prenatal smoking may predict behavioral problems 2In lab tests, the antimicrobial ingredient triclosan spurs growth of breast cancer cells 2Impact of whooping cough vaccination revealed 2
... will present the 2013 William Dameshek Prize to Andrew S. ... research on the cellular and molecular causes of blood clots. ... MD, a renowned hematologist, past president of ASH, and the ... an individual who has made a recent, outstanding contribution to ...
... known as important sources of energy for all organisms. ... certain types of sugars, known as polysaccharides, may also control ... produce hard structures such as shells and exoskeletons of mollusks, ... of the National Academy of Sciences , Anthony Giuffre, a ...
... is killing you, you may be right, but what you ... even before you were born. In a new report appearing ... Journal , Harvard researchers find that epigenetic disruptions, which ... common at birth. Possibly, these aberrations result from stressors in ...
Cached Biology News:The American Society of Hematology honors Andrew S. Weyrich, Ph.D., with 2013 William Dameshek Prize 2Geoscientists unearth mineral-making secrets potentially useful for new technologies 2Geoscientists unearth mineral-making secrets potentially useful for new technologies 3Fetal stress disrupts the way genes are transmitted 2
Assay Diluent, 10 L...
Assay Diluent Trial Pack, 4 x 100 mL...
HRP Monoclonal-Goat Diluent - 5X Concentrate, 25 mL...
SpectroQuest single beam 1.8nm UV/Vis spectrophotometer; stand-alone unit...
Biology Products: